About

Management Team

Rick Randall, President & CEO

rrandall@trans1.com

Rick Randall has been Chief Executive Officer and a member of the Board of Directors since June 2002. From June 2000 to June 2002, Mr. Randall served as President and Chief Executive Officer of Incumed, Inc., a privately-held medical device incubator company. From January 1994 to February 2000, he was President, Chief Executive Officer and a Director of Innovasive Devices, Inc., a developer, manufacturer and marketer of arthroscopic surgical products which was acquired by the Ethicon Division of Johnson & Johnson in 2000. Mr. Randall served as President and Chief Executive Officer of Conceptus, Inc. from December 1992 to July 1993 and Chief Financial Officer from December 1992 to January 1995. He served as President and Chief Executive Officer of Target Therapeutics, Inc., an interventional neurovascular medical device company which was acquired by Boston Scientific Corporation in 1997. Mr. Randall received a B.S. degree in Biology and Science Education from State University College of New York at Buffalo.

Ken Reali, President & COO

kreali@trans1.com

Ken Reali has been President and Chief Operating Officer since January 2010. Mr. Reali was most recently Senior Vice President and General of Smith & Nephew's Biologics and Spine Division prior to assuming his position with Trans1. Ken served 5 years at Smith & Nephew in positions including Vice President and General Manager of the Clinical Therapies Division. Mr. Reali worked at Stryker from 1998 to 2005 where he held positions of increasing responsibility in marketing and sales management. Ken started his career at Biomet where he progressed from Sales Representative of total joint implants, electrical stimulation products and external fixation for trauma applications to Marketing Product Manager for spinal fixation and implant development. Mr. Reali received a B.S. degree in Business with a minor in Math from Valparaiso University, Valparaiso, Indiana. Ken has completed executive management and business leadership courses at Harvard Business School and MIT's Sloan School of Management.

Rick Simmons, Vice President of Marketing and Sales

rsimmons@trans1.com

Rick Simmons has been Vice President, Marketing and Sales since November 2003. From 2000 to 2003 Mr. Simmons served as Vice President of Sales and Marketing at Nuvasive, Inc., a publicly traded minimally invasive spinal platform technology and implant company. From 1997 to 2000, he served as Vice President, Global Marketing and Sales for Innovasive Devices, Inc., a developer, manufacturer and marketer of arthroscopic surgical products which was acquired by the Ethicon Division of Johnson & Johnson in 2000. From 1995 to 1997, Mr. Simmons served as Director of Marketing, Managed Care and Business Development for Genzyme Tissue Repair, Inc., a human tissue engineering technology company serving the orthopaedic surgical sports medicine market and a publicly traded division within Genzyme Corporation. Mr. Simmons received a B.A. degree in Exercise Physiology from the California State University, Northridge.

Mike Luetkemeyer, Chief Financial Officer

mluetkemeyer@trans1.com

Michael Luetkemeyer has been Chief Financial Officer since April 2007. Prior to that, Mr. Luetkemeyer held various positions with Micromuse, Inc., a network management software provider that was acquired by IBM in 2006, including Chief Financial Officer from October 2001 to January 2005, interim Chief Executive Officer from January 2003 to August 2003, and Senior Vice President from February 2005 to March 2006. Mr. Luetkemeyer also served as a member of the board of directors of Micromuse from January 2003 to February 2005. Prior to joining Micromuse, he served as Chief Financial Officer of Aprisma Management Technologies, a network management software provider, from 2000 until October 2001, and held a variety of senior finance positions at GE Aerospace, GE Semiconductor and GE Plastics for more than ten years. Mr. Luetkemeyer received a B.S. degree in Finance from Southwest Missouri State, an M.A. degree in Economics from the University of Missouri and a B.S. degree in Accounting from Rollins College.

Rob Martin, Vice President of International Sales

rmartin@trans1.com

Robert Martin has been Vice President of International Sales since July 2007. From 2000 to June 2007, Mr. Martin served as Vice President of Global Sales and Marketing and, most recently, as President and CEO at Ascension Orthopedics Inc., a privately held extremity orthopedics company. From 1999 to 2000, he served as European Sales Manager for Innovasive Devices, Inc. a developer, manufacturer, and marketer of arthroscopic surgical products which was acquired by the Ethicon Division of Johnson & Johnson in 2000. From 1996 to 1999, Mr. Martin served as Sales and Marketing Manager for 3 divisions of Stryker Inc. (Canada), a publicly traded global orthopedic company. Mr. Martin received a B.A. degree in Physical Education from the University of Western Ontario.

Mickey Ramchandani, Vice President of Business Development

mickeyr@trans1.com

Mickey Ramchandani joined TranS1 as Vice President of Business Development in June 2008. Mr. Ramchandani has over 15 years experience in the life science industry, with experience ranging from research to marketing, business development and corporate strategy. Prior to TranS1, Mr. Ramchandani was at Kowa Research Institute, a US affiliate of a Japanese pharmaceutical company, Kowa Company Ltd. At Kowa, Mr. Ramchandani was responsible for all in-licensing, out-licensing and acquisitions. Prior to Kowa, Mr. Ramchandani started a device import and sales company called OBX Medical. Mr. Ramchandani also served at Baxter for 5 years, starting as a Senior Marketing Manager and for the last 3 years as Director, Global New Business. Mr. Ramchandani was also part of the Drug Discovery team at Pfizer from 1990 through 1994. Mr. Ramchandani received a B.S. in Chemistry from Campbell University, a M.S. in Organic Chemistry from East Carolina University and an MBA from UNC-Chapel Hill's Kenan-Flagler School of Business.